Hemophilia Gene Therapy: New Development from Bench to Bed Side

被引：7
作者：
Guo, Xiao-Lu [1 ,4 ]
Chung, Tsai-Hua [1 ,2 ]
Qin, Yue [2 ]
Zheng, Jie [3 ]
Zheng, Huyong [3 ]
Sheng, Liyuan [4 ]
Wynn, Tung [5 ,6 ]
Chang, Lung-Ji [1 ,2 ,3 ,7 ]
机构：
[1] Genoimmune Med Inst, 2nd F1 Key Lab Bldg,Shenzhen Virtual Univ Pk 6, Shenzhen 518000, Guangdong, Peoples R China
[2] Univ Elect Sci & Technol China, Sch Med, Chengdu, Sichuan, Peoples R China
[3] Capital Med Univ, Beijing Childrens Hosp, Hematol Oncol Ctr, Natl Ctr Childrens Hlth, Beijing, Peoples R China
[4] PKU HKUST Shenzhen Hong Kong Inst, Shenzhen, Guangdong, Peoples R China
[5] Univ Florida, Dept Pediat, Gainesville, FL USA
[6] Univ Florida, Div Hematol Oncol, Gainesville, FL USA
[7] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA
来源：
CURRENT GENE THERAPY | 2019年 / 19卷 / 04期
关键词：
Gene therapy; lentiviral vector; hemophilia; recessive disorder; novel gene therapy; hemostasis; FACTOR-VIII GENE; IMMUNE TOLERANCE INDUCTION; FACTOR-IX GENE; A MICE; CANINE HEMOPHILIA; EXPRESSION; DELIVERY; MODEL; CELLS; FVIII;
D O I：
10.2174/1566523219666190924121836
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Novel gene therapy strategies have changed the prognosis of many inherited diseases in recent years. New development in genetic tools and study models has brought us closer to a complete cure for hemophilia. This review will address the latest gene therapy research in hemophilia A and B including gene therapy tools, genetic strategies and animal models. It also summarizes the results of recent clinical trials. Potential solutions are discussed regarding the current barriers in gene therapy for hemophilia.
引用
收藏
页码：264 / 273
页数：10
相关论文
共 50 条
  • [21] Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives
    Bala, Natasha S.
    Thornburg, Courtney D.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2024,
  • [22] Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval
    Martini, Alberto
    Tholomier, Come
    Mokkapati, Sharada
    Dinney, Colin P. N.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] New technologies in gene therapy for inducing immune tolerance in hemophilia A
    Borsotti, Chiara
    Follenzi, Antonia
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (12) : 1013 - 1019
  • [24] Advances in gene therapy for hemophilia
    Olivia A Robles-Rodríguez
    José J Pérez-Trujillo
    Arnulfo Villanueva-Olivo
    Laura Villarreal-Martínez
    Luis J Marfil-Rivera
    Humberto Rodríguez-Rocha
    Aracely García-García
    Odila Saucedo-Cárdenas
    María J Loera-Arias
    Roberto Montes de Oca-Luna
    Journal of Biosciences, 2020, 45
  • [25] Application of Gene Therapy in Hemophilia
    Yue-fen Hu
    Yun-hai Fang
    Yong-rong Lai
    Xiao-qin Feng
    Shu-qian Xu
    Current Medical Science, 2022, 42 : 925 - 931
  • [26] Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
    Shoti, Jakob
    Qing, Keyun
    Srivastava, Arun
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [27] Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy
    Khan, Safir Ullah
    Khan, Munir Ullah
    Suleman, Muhammad
    Inam, Amrah
    Din, Muhammad Azhar Ud
    CURRENT GENE THERAPY, 2024, 24 (04) : 265 - 277
  • [28] Gene therapy for hemophilia: Current status and laboratory consequences
    Batty, Paul
    Lillicrap, David
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 : 117 - 123
  • [29] The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside
    Duplisea, Jonathan J.
    Mokkapati, Sharada
    Plote, Devin
    Schluns, Kimberly S.
    McConkey, David J.
    Yla-Herttuala, Seppo
    Parker, Nigel R.
    Dinney, Colin P.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (10) : 2041 - 2049
  • [30] Gene therapy for hemophilia: what does the future hold?
    Doshi, Bhavya S.
    Arruda, Valder R.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (09) : 273 - 293
12345